Pirfenidone exerts beneficial effects in patients with IPF undergoing single lung transplantation

Effect of Acute Exacerbation of Idiopathic Pulmonary Fibrosis on Lung Transplantation Outcome

(2018) Y. Dotan et al.   CHEST

Effect of antifibrotics on short-term outcome after bilateral lung transplantation: a multicentre analysis

(2018) Christopher Lambers et al.   EUROPEAN RESPIRATORY JOURNAL

Transcriptome profiling reveals the complexity of pirfenidone effects in IPF

(2018) Grazyna Kwapiszewska et al.   EUROPEAN RESPIRATORY JOURNAL

Lung volumes predict survival in patients with chronic lung allograft dysfunction

(2017) Nikolaus Kneidinger et al.   EUROPEAN RESPIRATORY JOURNAL

Safety and efficacy of pirfenidone in severe Idiopathic Pulmonary Fibrosis: A real-world observational study

(2017) Argyrios Tzouvelekis et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

Effect of Perioperative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis

(2016) Takekazu Iwata et al.   ANNALS OF THORACIC SURGERY

Core Muscle Size Predicts Postoperative Outcome in Lung Transplant Candidates

(2016) Thomas Weig et al.   ANNALS OF THORACIC SURGERY

Safety and efficacy of bridging to lung transplantation with antifibrotic drugs in idiopathic pulmonary fibrosis: a case series

(2016) Isabelle Delanote et al.   BMC Pulmonary Medicine

Bronchiolitis obliterans syndrome due to donor-specific HLA-antibodies

(2015) T. Kauke et al.   TISSUE ANTIGENS

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

(2014) Talmadge E. King et al.   NEW ENGLAND JOURNAL OF MEDICINE

Munich Lung Transplant Group: Waiting List during the First 9 Months of the Lung Allocation Score Era

(2013) Nikolaus Kneidinger et al.   THORACIC AND CARDIOVASCULAR SURGEON

Inhibitory Effects of Pirfenidone on Dendritic Cells and Lung Allograft Rejection

(2012) Peyman Bizargity et al.   TRANSPLANTATION

An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management

(2011) Ganesh Raghu et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials

(2011) Paul W Noble et al.   LANCET

Pirfenidone Inhibits T-Cell Activation, Proliferation, Cytokine and Chemokine Production, and Host Alloresponses

(2009) Gary A. Visner et al.   TRANSPLANTATION